Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Ethics declarations Competing interests SJW is the founder of Ridgeline Therapeutics, HN is a paid employee of Ridgeline Therapeutics and, since manuscript submission, ADW has also become a paid employee of Ridgeline Therapeutics
By selectively inhibiting nicotinamide N-methyltransferase (NNMT), 5-Amino-1MQ helps preserve intracellular NAD+ levels and redirect cellular energy metabolism toward enhanced fat oxidation and mitochondrial efficiency
These are the same pathways cancer cells exploit to grow and spread
Every cycle includes the compounded medication, the consultation with a licensed medical provider, dosing instructions, and post-cycle follow-up
the FDA has stated it lacks sufficient information to know whether the substance would cause harm when administered to humans Evidence snapshot: The evidence base is almost entirely preclinical, decades of animal (largely rat) studies, mostly from one Croatian research group (Sikiric et al., University of Zagreb), with a single small human trial under the brand name "Bepecin" (around 2015) that did not lead to any FDA-approved use
If you want carefully reviewed evidence and research-backed approaches to wellness, explore clinical resources and the Tonum research hub at Tonum Research
US$ 23.32
US$ 27.01
US$ 20.74
US$ 20.66
US$ 21.76
US$ 26.33
US$ 20.72
US$ 23.22
